Celera Diagnostics To Develop Genetic Tests For Hospitals And Labs
This article was originally published in The Gray Sheet
Executive Summary
Celera Diagnostics will develop genetic tests aimed at the $1 bil. molecular diagnostic market, which is currently growing at a 30% clip, as part of a recently launched business strategy to commercialize products based on analysis of the human genome.